{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-017562","form_type":"8-K","ticker":"PVCT","cik":"0000315545","company_name":"PROVECTUS BIOPHARMACEUTICALS, INC.","filed_at":"2022-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.179757+00:00","generated_at":"2026-06-24T23:45:29.111887+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Provectus shareholders approve reverse stock split, elect directors at annual meeting","bullets":["All five director nominees elected: Bailey, Horowitz, Lacey, Pershing, Rodrigues; 102.4M broker non-votes.","Advisory say-on-pay approved with 206.7M for vs 9.6M against.","Ratification of Marcum LLP as auditor for 2022 passed with 313.4M for.","Authorization to implement reverse stock split (1:10 to 1:50) approved with 300.5M for.","Authorization to reduce authorized shares proportionally to reverse split ratio approved with 302.5M for."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-017562","json":"https://secwatch.observer/filing/0001493152-22-017562.json","markdown":"https://secwatch.observer/filing/0001493152-22-017562.md","text":"https://secwatch.observer/filing/0001493152-22-017562.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/315545/000149315222017562/0001493152-22-017562-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/315545/000149315222017562/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T23:45:29.111887+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}